The Venture Codex

Participated · Equity · May 2026

Memed offers electronic prescription software and positions itself as an infrastructure platform for digitalizing clinical workflows. The company is incorporating AI centrally into the prescription act to deliver context on drug interactions, patient-tailored dosing and clinical alerts at the point of prescribing. Management plans include launching new AI-driven prescription features, expanding integrations with electronic health records and hospital systems, and deepening its structured clinical data layer. Memed reached breakeven in June 2025, is currently profitable, and projects R$100 million in revenue for 2026. CEO Rodolfo Chung has shifted the company toward monetization opportunities with the pharmaceutical industry while pursuing broader clinical-product expansion and longer-term ambitions to become a unicorn within four to five years and maintain runway toward a potential IPO.

Led · Seed · Apr 2022

Reema Health partners with health plans to reduce total cost of care, boost revenue, and increase effective healthcare utilization among difficult-to-reach members. Its model combines community-based "guides" who live in the neighborhoods they serve with proprietary technology, predictive analytics, and algorithms that pinpoint high-risk, high-cost individuals most likely to benefit from preventive services. The platform directs guides to deliver in-person, high-touch support while scaling engagement capacity through precision outreach tools. Over the past year, Reema Health expanded operations from four to 14 markets and plans launches in three additional states in early 2026. The company is also broadening its program portfolio to include maternal health and other offerings tailored to Medicaid Managed Care Organizations and health plans. These efforts aim to maintain meaningful member connections while demonstrating measurable return on investment. Financial details beyond funding were not disclosed, but the firm’s rapid geographic growth underscores strong market traction.

Led · Equity · Apr 2022

Inspirali consolidates Ânima’s portfolio of medical schools and positions itself as a platform for medical education and lifelong learning in Brazil. The unit reached nearly 10,000 undergraduate students in 2021, a >300% increase year-on-year, and already accounts for 25% of Ânima’s net revenue. Recent moves include the November acquisition of 51% of IBCMED (postgraduate health courses) and launch of an Inspirali-integrated curriculum across former Laureate schools for the 2022 academic year. The group also secured MEC authorization for a Medicine course in Brumado (BA) in December 2021. Planned initiatives emphasize strengthening ties between academia and healthcare, scaling a lifelong-learning platform, driving educational-innovation networks, and improving student experience and employability. Leadership reports recent operational reinforcement, strategic expansion, academic integration and technology investment to prepare Inspirali for accelerated growth.

Led · Series A · Mar 2022

Nice Healthcare provides a fully integrated clinic model that delivers in-home and virtual primary care, mental health therapy, and physical therapy using technology, logistics, and expert clinicians. Its clinicians can offer x-rays, 35 labs and blood draws, and a formulary with over 550 medications with no out-of-pocket costs. The company is led by CEO Thompson Aderinkomi and is available in parts of Arizona, Colorado, Idaho, Minnesota, Nebraska, New Mexico, Nevada, Utah, Iowa, Wisconsin, Oregon and Washington. More than 400 small businesses currently use Nice Healthcare for employee healthcare benefits. The company plans to use recent funding to expand into more markets. Recent executive hires include a Chief Experience Officer, Chief Financial Officer, and Chief People Officer. Nice Healthcare delivers in-home and virtual primary care services, contracting directly with small and medium businesses to provide unlimited access under a capitated rate. The company offers in-home visits, virtual visits, in-home labs and x-rays, virtual physical therapy, chronic condition management, and a formulary of 550+ medications. It charges a transparent $30–$36 per employee per month with dependents included and no visit fees. Since launching in October 2017, Nice clinicians serve over 200 small businesses encompassing 30,000+ members and currently operate in five states. The company targets small employers (many with fewer than 50 employees and some as small as five) and focuses on expanding into underserved cities and rural areas. Nice plans to use the new financing to launch its model into several new markets, with a plan to open 10 new markets in early 2021.

Participated · Series B · Apr 2021

Beep Saúde operates in the home healthcare space, offering at-home medical services and a diagnostic medicine unit. The company says it will use new capital to expand its diagnostic unit and to reach breakeven. Management projects revenue of R$250 million for 2023. The funding is intended to support scaling of its home-care and diagnostics offerings. The investment was reported as part of the company’s push to grow its clinical and diagnostic capabilities. Founded in 2016 by physician Vander Corteze, Beep Saúde runs a technology platform delivering home healthcare services, initially focusing on at‑home vaccinations and now offering at‑home lab tests and diagnostic services. The company operates in Rio de Janeiro, the Federal District, São Paulo and Paraná and is described in the article as the largest home‑healthcare provider in Brazil. Its service portfolio includes vaccines, newborn heel‑prick tests, fetal sexing and COVID‑19 testing, and it serves beneficiaries of private health plans such as Bradesco and Care Plus. Beep employs about 500 people, has more than 250 open positions and expects to reach roughly 1,000 employees by the end of 2021. The company plans to expand its geographic footprint across Brazil and to broaden services into areas such as infusion and medication delivery with the goal of becoming a one‑stop shop for home healthcare.